In an ICC dispute, CRA was retained by respondent regarding the renegotiation of price in a supply agreement for a pharmaceutical sold in Japan. In expert reports and testimony, CRA evaluated the adequacy of returns made by respondent with request to development and commercialization of the product for the Japanese market.
Damages in Life Sciences Arbitration
In this chapter published in The Guide to Damages in International Arbitration, Gregory Bell, Andrew Tepperman, and Justin Ho provide a brief overview of...